Literature DB >> 25075001

Gadolinium deposits could influence the course of encapsulating peritoneal sclerosis.

Joerg Latus1, Eric Goffin1, Josef A Schroeder1, Peter Fritz1, German Ott1, Christoph Ulmer1, Wolfgang Steurer1, Martin Kimmel1, Dagmar Biegger1, Stephan Segerer1, M Dominik Alscher1, Niko Braun2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25075001      PMCID： PMC4114676          DOI： 10.3747/pdi.2013.00137

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  19 in total

Review 1.  Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.

Authors:  Y Kawaguchi; H Kawanishi; S Mujais; N Topley; D G Oreopoulos
Journal:  Perit Dial Int       Date:  2000       Impact factor: 1.756

Review 2.  Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment.

Authors:  Hidetomo Nakamoto
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

3.  Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?

Authors:  H S Thomsen; S K Morcos; P Dawson
Journal:  Clin Radiol       Date:  2006-11       Impact factor: 2.350

4.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

Review 5.  Posttransplant encapsulating peritoneal sclerosis: a worrying new trend?

Authors:  Marien W J A Fieren; Michiel G H Betjes; Mario R Korte; Walther H Boer
Journal:  Perit Dial Int       Date:  2007 Nov-Dec       Impact factor: 1.756

6.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

Authors:  Peter Marckmann; Lone Skov; Kristian Rossen; Anders Dupont; Mette Brimnes Damholt; James Goya Heaf; Henrik S Thomsen
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

7.  Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.

Authors:  Josef A Schroeder; Christian Weingart; Brigitte Coras; Ingrid Hausser; Stephan Reinhold; Matthias Mack; Volker Seybold; Thomas Vogt; Bernhard Banas; Ferdinand Hofstaedter; Bernhard K Krämer
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

8.  Phenotypes of encapsulating peritoneal sclerosis--macroscopic appearance, histologic findings, and outcome.

Authors:  Joerg Latus; Christoph Ulmer; Peter Fritz; Bianka Rettenmaier; Dagmar Biegger; Thomas Lang; German Ott; Martin Kimmel; Wolfgang Steurer; M Dominik Alscher; Stephan Segerer; Niko Braun
Journal:  Perit Dial Int       Date:  2013-02-01       Impact factor: 1.756

Review 9.  Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.

Authors:  Fabian A Mendoza; Carol M Artlett; Nora Sandorfi; Kevin Latinis; Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Semin Arthritis Rheum       Date:  2006-02       Impact factor: 5.532

10.  Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis.

Authors:  Hideki Kawanishi; Misaki Moriishi; Kentaro Ide; Kiyohiko Dohi
Journal:  Perit Dial Int       Date:  2008-06       Impact factor: 1.756
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.